The above mentioned diseases, especially ET and PV, account for the majority of patients with non-reactive elevated platelet counts, suggesting that JAK2 V617F plays an important role in patients with non-reactive elevated platelet counts. Here, JAK2 is linked to essential thrombocythemia.